Informations techniques
Exploitant
Laboratoires PROSTRAKAN PHARMA
Présentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
ccKSYXe3GtwsTnGr